Exact Mass: 527.1405186
Exact Mass Matches: 527.1405186
Found 182 metabolites which its exact mass value is equals to given mass value 527.1405186
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Daunorubicin
C27H29NO10 (527.1791374000001)
Daunorubicin is only found in individuals that have used or taken this drug. It is a very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms. [PubChem]Daunorubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Daunorubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors KEIO_ID D106
4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp
C20H33NO15 (527.1850108000001)
An O(4)-glycosyl-L-hydroxyproline that is cis-L-hydroxylproline glycosylated by a beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf moiety
Lumefantrine
C30H32Cl3NO (527.1549352000001)
Lumefantrine is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with artemether for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
5-Carboxytetramethylrhodamine succinimidyl ester
C29H25N3O7 (527.1692419999999)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines
2-(Dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol
C30H32Cl3NO (527.1549352000001)
Esorubicin
C27H29NO10 (527.1791374000001)
D000970 - Antineoplastic Agents
N-Demethylmenogaril
C27H29NO10 (527.1791374000001)
Cerubidin
C27H29NO10 (527.1791374000001)
Pirozadil
C27H29NO10 (527.1791374000001)
(2,6-epoxy-1,2alpha,3beta,4alpha,5alpha-pentahydroxy)hexane-(1->6)-5,6-dihydrochelerythrine|maclekarpine D
C27H29NO10 (527.1791374000001)
Daunorubicin
C27H29NO10 (527.1791374000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent A natural product found in Actinomadura roseola. D004791 - Enzyme Inhibitors
Cys Asp Gln Tyr
C21H29N5O9S (527.1685904000001)
Cys Asp Tyr Gln
C21H29N5O9S (527.1685904000001)
Cys Glu Asn Tyr
C21H29N5O9S (527.1685904000001)
Cys Glu Tyr Asn
C21H29N5O9S (527.1685904000001)
Cys Phe Met Gln
C22H33N5O6S2 (527.1872158000001)
Cys Phe Gln Met
C22H33N5O6S2 (527.1872158000001)
Cys Gly Trp Tyr
Cys Gly Tyr Trp
Cys Met Phe Gln
C22H33N5O6S2 (527.1872158000001)
Cys Met Gln Phe
C22H33N5O6S2 (527.1872158000001)
Cys Asn Glu Tyr
C21H29N5O9S (527.1685904000001)
Cys Asn Tyr Glu
C21H29N5O9S (527.1685904000001)
Cys Gln Asp Tyr
C21H29N5O9S (527.1685904000001)
Cys Gln Phe Met
C22H33N5O6S2 (527.1872158000001)
Cys Gln Met Phe
C22H33N5O6S2 (527.1872158000001)
Cys Gln Tyr Asp
C21H29N5O9S (527.1685904000001)
Cys Trp Gly Tyr
Cys Trp Tyr Gly
Cys Tyr Asp Gln
C21H29N5O9S (527.1685904000001)
Cys Tyr Glu Asn
C21H29N5O9S (527.1685904000001)
Cys Tyr Gly Trp
Cys Tyr Asn Glu
C21H29N5O9S (527.1685904000001)
Cys Tyr Gln Asp
C21H29N5O9S (527.1685904000001)
Cys Tyr Trp Gly
Asp Cys Gln Tyr
C21H29N5O9S (527.1685904000001)
Asp Cys Tyr Gln
C21H29N5O9S (527.1685904000001)
Asp Gln Cys Tyr
C21H29N5O9S (527.1685904000001)
Asp Gln Tyr Cys
C21H29N5O9S (527.1685904000001)
Asp Tyr Cys Gln
C21H29N5O9S (527.1685904000001)
Asp Tyr Gln Cys
C21H29N5O9S (527.1685904000001)
Glu Cys Asn Tyr
C21H29N5O9S (527.1685904000001)
Glu Cys Tyr Asn
C21H29N5O9S (527.1685904000001)
Glu Asn Cys Tyr
C21H29N5O9S (527.1685904000001)
Glu Asn Tyr Cys
C21H29N5O9S (527.1685904000001)
Glu Tyr Cys Asn
C21H29N5O9S (527.1685904000001)
Glu Tyr Asn Cys
C21H29N5O9S (527.1685904000001)
Phe Cys Met Gln
C22H33N5O6S2 (527.1872158000001)
Phe Cys Gln Met
C22H33N5O6S2 (527.1872158000001)
Phe Met Cys Gln
C22H33N5O6S2 (527.1872158000001)
Phe Met Gln Cys
C22H33N5O6S2 (527.1872158000001)
Phe Gln Cys Met
C22H33N5O6S2 (527.1872158000001)
Phe Gln Met Cys
C22H33N5O6S2 (527.1872158000001)
Gly Cys Trp Tyr
Gly Cys Tyr Trp
Gly Trp Cys Tyr
Gly Trp Tyr Cys
Gly Tyr Cys Trp
Gly Tyr Trp Cys
Met Cys Phe Gln
C22H33N5O6S2 (527.1872158000001)
Met Cys Gln Phe
C22H33N5O6S2 (527.1872158000001)
Met Phe Cys Gln
C22H33N5O6S2 (527.1872158000001)
Met Phe Gln Cys
C22H33N5O6S2 (527.1872158000001)
Met Gln Cys Phe
C22H33N5O6S2 (527.1872158000001)
Met Gln Phe Cys
C22H33N5O6S2 (527.1872158000001)
Asn Cys Glu Tyr
C21H29N5O9S (527.1685904000001)
Asn Cys Tyr Glu
C21H29N5O9S (527.1685904000001)
Asn Glu Cys Tyr
C21H29N5O9S (527.1685904000001)
Asn Glu Tyr Cys
C21H29N5O9S (527.1685904000001)
Asn Tyr Cys Glu
C21H29N5O9S (527.1685904000001)
Asn Tyr Glu Cys
C21H29N5O9S (527.1685904000001)
Gln Cys Asp Tyr
C21H29N5O9S (527.1685904000001)
Gln Cys Phe Met
C22H33N5O6S2 (527.1872158000001)
Gln Cys Met Phe
C22H33N5O6S2 (527.1872158000001)
Gln Cys Tyr Asp
C21H29N5O9S (527.1685904000001)
Gln Asp Cys Tyr
C21H29N5O9S (527.1685904000001)
Gln Asp Tyr Cys
C21H29N5O9S (527.1685904000001)
Gln Phe Cys Met
C22H33N5O6S2 (527.1872158000001)
Gln Phe Met Cys
C22H33N5O6S2 (527.1872158000001)
Gln Met Cys Phe
C22H33N5O6S2 (527.1872158000001)
Gln Met Phe Cys
C22H33N5O6S2 (527.1872158000001)
Gln Tyr Cys Asp
C21H29N5O9S (527.1685904000001)
Gln Tyr Asp Cys
C21H29N5O9S (527.1685904000001)
Trp Cys Gly Tyr
Trp Cys Tyr Gly
Trp Gly Cys Tyr
Trp Gly Tyr Cys
Trp Tyr Cys Gly
Trp Tyr Gly Cys
Tyr Cys Asp Gln
C21H29N5O9S (527.1685904000001)
Tyr Cys Glu Asn
C21H29N5O9S (527.1685904000001)
Tyr Cys Gly Trp
Tyr Cys Asn Glu
C21H29N5O9S (527.1685904000001)
Tyr Cys Gln Asp
C21H29N5O9S (527.1685904000001)
Tyr Cys Trp Gly
Tyr Asp Cys Gln
C21H29N5O9S (527.1685904000001)
Tyr Asp Gln Cys
C21H29N5O9S (527.1685904000001)
Tyr Glu Cys Asn
C21H29N5O9S (527.1685904000001)
Tyr Glu Asn Cys
C21H29N5O9S (527.1685904000001)
Tyr Gly Cys Trp
Tyr Gly Trp Cys
Tyr Asn Cys Glu
C21H29N5O9S (527.1685904000001)
Tyr Asn Glu Cys
C21H29N5O9S (527.1685904000001)
Tyr Gln Cys Asp
C21H29N5O9S (527.1685904000001)
Tyr Gln Asp Cys
C21H29N5O9S (527.1685904000001)
Tyr Trp Cys Gly
Tyr Trp Gly Cys
Benflumetol
C30H32Cl3NO (527.1549352000001)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
fluphenazine n-mustard dihydrochloride
C22H27Cl3F3N3S (527.0943268000001)
Pirozadil
C27H29NO10 (527.1791374000001)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98151 - Niacin-based Antilipidemic Agent
3,5-dichloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide
[3,4,5-triacetyloxy-6-[(2-nitrophenyl)carbamothioylamino]oxan-2-yl]methyl acetate
p-[4,5-dihydro-3-methyl-4-[[4-methyl-3-[(phenylamino)sulphonyl]phenyl]azo]-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid
C23H21N5O6S2 (527.0933206000001)
Benzenepropanoic acid, 4-[[4-(4-methoxyphenyl)-5-[4-(trifluoromethyl)phenyl]-2-thiazolyl]methoxy]-2-methyl-
C28H24F3NO4S (527.1378060000001)
Barnidipine
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
5(6)-CARBOXYTETRAMETHYLRHODAMINE N-SUCCINIMIDYL ESTER
C29H25N3O7 (527.1692419999999)
VT-1161
J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives C254 - Anti-Infective Agent > C514 - Antifungal Agent
Hydro-tris(3-phenylpyrazol-1-yl)borate potassium salt
5(6)-TAMRA, SE [5-(and-6)-Carboxytetramethylrhodamine, succinimidyl ester]
C29H25N3O7 (527.1692419999999)
(R)-2-(3-(3-(4-methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl)phenoxy)butanoic acid
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-6,8-dimethyl-2-(2-pyridinyl)-4-quinolinecarboxamide
Lumefantrine
C30H32Cl3NO (527.1549352000001)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
2-(dibutylamino)-1-{2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl}ethan-1-ol
C30H32Cl3NO (527.1549352000001)
(7S,9S)-9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-6,8-dimethyl-2-(3-pyridinyl)-4-quinolinecarboxamide
[4-({3-[2-(1H-indol-3-yl)ethyl]-2-[(4-methoxyphenyl)imino]-4-oxo-1,3-thiazolidin-5-ylidene}methyl)phenoxy]acetic acid
[4-[2-(4-Bromophenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]-(3-furanyl)methanone
C27H22BrN5O2 (527.0956772000001)
(7R,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
2-[[4-(4-chlorophenyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]thio]-N-(3-methoxyphenyl)-2-phenylacetamide
2-[(1S,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
(2R,4S)-4-[[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]methyl]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-2-carboxylic acid
C27H29NO10 (527.1791374000001)
2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1R,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
N3-[4-(difluoromethoxy)phenyl]-1-(3,4-dimethylphenyl)-N7-(2-hydroxyethyl)-2-mercaptoimidazo[1,2-a]pyridin-4-ium-3,7-dicarboxamide
C26H25F2N4O4S+ (527.1564493999999)
9-acetyl-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp zwitterion
C20H33NO15 (527.1850108000001)
An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of 4-O-(beta-L-Araf-(1->2)-beta-L-Araf-(1->2)-beta-L-Araf)-cis-L-Hyp.
Beperidium iodide
Beperidium iodide shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93.
10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
(10r)-3-hydroxy-23,24-dimethoxy-10-methyl-9,20-dioxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2,4(12),13,15,19(28),21,23,25-nonaene-5,18,27,29-tetrone
(7r,10r)-3,22,29-trihydroxy-10-methyl-5,20,27-trioxo-9-oxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2(14),3,12,18,21,23,25,28-nonaene-7-carboxylic acid
(2s,3s,4r,5r)-2-[(s)-[(20s)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl](hydroxy)methyl]oxane-2,3,4,5-tetrol
C27H29NO10 (527.1791374000001)
12-(3,4-dimethoxyphenyl)-7-hydroxy-8,16,17-trimethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17,20-nonaen-3-one
3,22,29-trihydroxy-10-methyl-5,20,27-trioxo-9-oxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2(14),3,12,18,21,23,25,28-nonaene-7-carboxylic acid
(8s,10s)-8-acetyl-10-{[(2r,4r,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
(8s,10r)-10-{[(2s,4r,5r,6r)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
18-ethyl-9,10,20-trihydroxy-8-methoxy-7,20,23-trimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15-trione
C27H29NO10 (527.1791374000001)
(8s,10s)-10-{[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-8,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
C27H29NO10 (527.1791374000001)
3-hydroxy-23,24-dimethoxy-10-methyl-9,20-dioxa-6-azaheptacyclo[15.12.0.0²,¹⁴.0⁴,¹².0⁶,¹⁰.0¹⁹,²⁸.0²¹,²⁶]nonacosa-1(17),2,4(12),13,15,19(28),21,23,25-nonaene-5,18,27,29-tetrone
(5s,7r,8s,9r,10r,18r,20r)-18-ethyl-9,10,20-trihydroxy-8-methoxy-7,20,23-trimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15-trione
C27H29NO10 (527.1791374000001)
2-({17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl}(hydroxy)methyl)oxane-2,3,4,5-tetrol
C27H29NO10 (527.1791374000001)